Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17, 11-20
- https://doi.org/10.1016/0305-7372(90)90011-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cellsBritish Journal of Cancer, 1990
- Multidrug resistance and its circumventionEuropean Journal of Cancer and Clinical Oncology, 1990
- Protein kinase C-γ is present in adriamycin resistant HL-60 leukemia cellsBiochemical and Biophysical Research Communications, 1990
- Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cellsBiochemical Pharmacology, 1989
- Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulationBlood, 1989
- Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cellsBiochemical Pharmacology, 1988
- Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastineBiochemical and Biophysical Research Communications, 1988
- Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cellsThe FASEB Journal, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Cytofluorescence localization of adriamycin in resistant colon cancer cellsCancer Chemotherapy and Pharmacology, 1984